These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
56 related articles for article (PubMed ID: 1209053)
1. [Treatment of parkinsonian syndrome with Ro 8-0576]. Bernales JV; Mere AF; Portillo R Rev Neuropsiquiatr; 1975 Jun; 38(2):65-73. PubMed ID: 1209053 [No Abstract] [Full Text] [Related]
2. [A year of treatment with carbidopa and levodopa in Parkinsonian patients]. Martínez-Lage JM; Marti-Massó JF; Delgado G; Carreray N; Del Amo F Rev Clin Esp; 1974 Sep; 134(6):535-42. PubMed ID: 4450036 [No Abstract] [Full Text] [Related]
3. [Aspects of long-term treatment with levodopa alone and levodopa combined with dopa decarboxylase inhibitors]. Cinca I; Serbănescu A; Tudorache B Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Neurol Psihiatr Neurochir; 1982; 27(4):261-70. PubMed ID: 6222452 [No Abstract] [Full Text] [Related]
4. Comparison of efficacy of lisuride hydrogen maleate with increased doses of levodopa in parkinsonian patients. Rabey JM; Treves T; Streifler M; Korczyn AD Adv Neurol; 1987; 45():569-72. PubMed ID: 3825734 [No Abstract] [Full Text] [Related]
6. [The treatment of Parkinson disease using the combination bromocriptine and levodopa]. Dufresne JJ Rev Med Suisse Romande; 1990 Jun; 110(6):559-64. PubMed ID: 2367793 [No Abstract] [Full Text] [Related]
7. [Early or late onset of L-dopa treatment in Parkinson disease?]. von Kummer R; Schneevoigt K Nervenarzt; 1986 Nov; 57(11):634-9. PubMed ID: 3808131 [No Abstract] [Full Text] [Related]
8. [Our experience in the treatment of Parkinson's disease with L-dopa plus RO 4-4602 combination]. Campanella G; Pennetta R Acta Neurol (Napoli); 1974; 29(3):252-63. PubMed ID: 4417098 [No Abstract] [Full Text] [Related]
9. [Oral lisuride in Parkinson's disease]. Obeso JA; Luquin MR; Martínez Lage JM Med Clin (Barc); 1985 Sep; 85(8):307-12. PubMed ID: 4068822 [No Abstract] [Full Text] [Related]
10. [Pergolide: a useful agonist for the treatment of Parkinson disease]. Bonnet AM; Houeto JL Rev Neurol (Paris); 2002 Jul; 158(6-7):744-5. PubMed ID: 12486908 [TBL] [Abstract][Full Text] [Related]
11. Current controversies: levodopa in the treatment of Parkinson's disease. Sharma JC; Vassallo M; Ross IN Mov Disord; 2005 May; 20(5):642-3; author reply 643-4. PubMed ID: 15732129 [No Abstract] [Full Text] [Related]